2019 Year in Review
As we enter 2020, we’re taking a moment to look back at the incredible advancements of 2019. From forming new precision medicine partnerships to sending multiple...
43 Results
Clear Filters
NYSCF Collaboration Sends Multiple Sclerosis and Parkinson’s Disease Brain Cells to Space
Brain cells derived from the stem cells of multiple sclerosis and Parkinson’s disease patients are on their way up to the International Space Station! This afternoon,...
First-in-kind Human 3-dimensional Models of Parkinson’s Disease and Progressive Multiple Sclerosis Launching to the International Space Station
First patient-derived, induced pluripotent stem cell disease-specific organoid models in microgravity to advance understanding of neurodegenerative disease LOUISVILLE, KY — (BUSINESS WIRE) — The National Stem...
NYSCF, Johns Hopkins, and Bloomberg Philanthropies Partner to Advance Precision Medicine
A new collaboration between the NYSCF Research Institute, Johns Hopkins University School of Medicine (JHUSOM), and Bloomberg Philanthropies is aiming to push precision medicine forward using...
Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine
Unmatched Scope of Resources Will Identify Distinctive Disease Mechanisms in Small Patient Subgroups, Supporting Development of Custom Therapeutic Approaches New York, NY (October 22, 2019) –...
New Hope for a Rare and Deadly Neurological Disease
The Context: Pelizaeus – Merzbacher disease (PMD) is a rare neurological condition typically diagnosed in infancy which often becomes fatal by a patient’s teenage years. While...
Stem Cells Take to Space: NYSCF Collaboration Launches the First 3D Models of Parkinson’s Disease and Multiple Sclerosis to the International Space Station
On Thursday evening, SpaceX cargo flight CRS-18 took off from Cape Canaveral, bound for the International Space Station (ISS). Aboard for the 250-mile journey were brain...
NYSCF Collaboration Finds Possible Mechanism Behind Tired Brain Cells in Progressive MS
The Context: In multiple sclerosis (MS), brain cells degenerate and malfunction, leaving patients with symptoms such as numbness, weakness, vision loss, tremor, fatigue, and cognitive impairment....
The Science of Startups: Drs. Derrick Rossi and Paul Tesar Discuss How Their Biotechs Are Bringing Stem Cell Research to Patients
“We had the foundational tools we needed to move our research from academia to biotech,” remarked NYSCF – Robertson Investigator Alumnus Dr. Paul Tesar. “We had...
NYSCF Collaboration Uncovers New Target for Progressive Multiple Sclerosis Therapies
The Context: In multiple sclerosis, the immune system attacks myelin (the fatty substance that surrounds neurons and helps them send signals). Currently, there are no...
Dr. Valentina Fossati Hunts for the Biomarkers Behind MS
What They Did: Researchers at the National Institutes of Health (NIH) and Montana State University along with NYSCF Senior Principal Investigator Dr. Valentina Fossati examined cerebrospinal...
Unique Collaboration Utilizing the International Space Station Accelerates Parkinson’s Disease and Multiple Sclerosis Research
The National Stem Cell Foundation (NSCF), Summit for Stem Cell Foundation, The New York Stem Cell Foundation (NYSCF) Research Institute, and Space Tango today announced a...
NYSCF Collaboration Adds Missing Functionality to Brain Organoids
Protocol adds a new cell type enabling myelination in human ‘mini-brains’ for laboratory research New York, NY (July 25, 2018) – In a collaborative study between...
Dr. Valentina Fossati Featured In Neuro Central
Recently, NYSCF Research Institute Senior Investigator Valentina Fossati, PhD, was featured in an article from Neuro Central about the current state of multiple sclerosis (MS) research...
NYSCF Innovators Derive Microglia From Stem Cells
Your body is full of immune cells that fight off infection and illness. You’ve probably heard of a few of them: white blood cells, B cells,...
NYSCF Innovator Shows Nerve Cells Resist Transforming Into Other Cell Types
NYSCF – Robertson Stem Cell Investigator Alumnus and NYSCF – Robertson Stem Cell Prize recipient Dr. Marius Wernig of Stanford University published exciting results showing that nerve...
Five Women Unite to Crack the Code of Multiple Sclerosis
In a collaborative tour de force, five female principal investigators, including NYSCF’s own Dr. Valentina Fossati, are uncovering the cellular mechanisms behind multiple sclerosis (MS). Over...
Dr. Oz Exposes Bogus Stem Cell Treatments
NYSCF Chief of Staff David McKeon appeared on the Dr. Oz Show investigation “Exposing Experimental Stem Cell Treatments.” The segment highlighted the dangers of unproven stem...
NYSCF Research Institute Teams Up With National Stem Cell Foundation to Advance Neurodegeneration Research
The National Stem Cell Foundation (NSCF) and the NYSCF Research Institute announced that a grant from NSCF will be used to fund NYSCF research on cell...
NYSCF Highlights Stem Cell Technology for Multiple Sclerosis Research in Paris
NYSCF Principal Investigator Dr. Valentina Fossati shared how stem cell technology has revolutionized multiple sclerosis research during the session on remyelination at the Multiple Sclerosis Meeting...
NYSCF Team Uses The Power of Stem Cells To Understand Brain Cell Development
NYSCF Principal Investigator Dr. Valentina Fossati and a team of NYSCF Research Institute scientists continued to unravel the mysteries of multiple sclerosis with her latest paper...
Spotlighting International Multiple Sclerosis Awareness Month
NYSCF spoke with Dr. Valentina Fossati who leads NYSCF’s multiple sclerosis research on the future of MS treatments and how stem cells have changed the field...
NYSCF Scientists Accelerate Multiple Sclerosis Research With New Protocol
NYSCF Principal Investigator Dr. Valentina Fossati and NYSCF – Druckenmiller Postdoctoral Fellow Dr. Panagiotis Douvaras have improved a method for deriving oligodendrocyte progenitor cells – the types...
NYSCF – Robertson Investigator Makes Advances in Multiple Sclerosis Research
NYSCF – Robertson Stem Cell Investigator Dr. Paul Tesar, Case Western Reserve School of Medicine, and a team of scientists discovered that two drugs, one used...
NYSCF Scientists One Step Closer to Cell Replacement Therapies for MS
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they...